The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties
Giuseppe Lippi, Brandon Michael Henry, Emmanuel J. Favaloro
Abstract
Coronavirus disease 2019 (COVID-19), a life-threatening infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing the worst pandemic outbreak since the Spanish flu of 1918–1919.[1]
Topics & Concepts
HeparinCoronavirus disease 2019 (COVID-19)AnticoagulantMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineImmunologyPharmacologyVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesVenous Thromboembolism Diagnosis and ManagementSARS-CoV-2 and COVID-19 Research